People with low levels of vitamin D have a higher likelihood of developing Alzheimer’s disease and Parkinson’s disease.
See the scientific wording
Vitamin D deficiency is associated with an increased risk of neurodegenerative diseases, including Alzheimer’s disease and Parkinson’s disease.
Correlational — new studies may shift this
One low-scoring study links this claim to the outcome, but causation is not established.
What the research says
1 study reviewedSupporting (1)
Narrative ReviewReview
This study says vitamin D helps your body work properly, including your brain and immune system, which could explain why low levels might be linked to brain diseases like Alzheimer’s — but it doesn’t prove it causes them.
Contradicting (0)
No contradicting studies found yet
That doesn't mean it's settled — it just means no study has tested the opposite.
Quality-weighted scoring: we follow the GRADE framework — each study is rated High, Moderate, Low, or Very Low based on study design, methodology rigor, and risk of bias. A single high-quality RCT can outweigh several weaker observational studies.
Scores reflect study quality, not just count.
When vitamin D is low, the brain loses its ability to protect nerve cells from damage and control inflammation. This happens because calcium levels inside nerve cells drop, making them more vulnerable to stress, and immune cells in the brain become overactive, releasing harmful chemicals that kill neurons over time.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting study
How Fit Body Science checks a claim
- 1
We isolate the claim
Health advice from videos, articles and studies is broken down into single, testable claims.
- 2
We find the research
Each claim is matched against peer-reviewed studies, with every source cited by DOI.
- 3
We grade the evidence
Studies are scored on methodology, statistical rigor, transparency and publication quality.
The fitness and health internet is full of confident claims. We check them against real research.
Every claim on this site is traced back to peer-reviewed studies, scored on methodology and reporting quality, and given a verdict you can audit yourself — sources, DOIs and all.
- Full evidence breakdown and mechanism chains
- Ask our AI anything about a claim or its studies
- Get notified when new research changes a verdict
People with low levels of vitamin D have a higher likelihood of developing Alzheimer’s disease and Parkinson’s disease.
Mechanism
1 studyLow vitamin D means brain cells get less protection and more inflammation. Calcium inside nerve cells doesn't work right, harmful chemicals build up, and immune cells in the brain start attacking neurons. Over time, this kills brain cells and leads to diseases like Alzheimer’s and Parkinson’s.
When vitamin D is low, the brain loses its ability to protect nerve cells from damage and control inflammation. This happens because calcium levels inside nerve cells drop, making them more vulnerable to stress, and immune cells in the brain become overactive, releasing harmful chemicals that kill neurons over time.
Reduced calcitriol levels decrease vitamin D receptor activation in neurons and glial cells
Downregulation of neurotrophic factors (NGF, GDNF) and neurotransmitter-synthesizing enzymes (tyrosine hydroxylase, tryptophan hydroxylase 2) reduces dopamine and serotonin production
Impaired calcium transport protein expression (SERCA, calbindin-D9k) disrupts intracellular calcium flux in neurons
Reduced antioxidant gene expression increases neuronal oxidative stress and mitochondrial dysfunction
Vitamin D receptor signaling loss in microglia and astrocytes increases pro-inflammatory cytokine production (TNF-α, IL-6) and reduces anti-inflammatory Treg activity
Chronic neuroinflammation and oxidative damage trigger protein misfolding, synaptic loss, and neuronal death in vulnerable brain regions
Evidence from Studies
Supporting (1)
Community contributions welcome
This study says vitamin D helps your body work properly, including your brain and immune system, which could explain why low levels might be linked to brain diseases like Alzheimer’s — but it doesn’t prove it causes them.
Contradicting (0)
Community contributions welcome
Score Breakdown
No multi-axis breakdown available yet. The overall Pro / Against score above is the best signal.
Clinical support requires direct evidence. Mechanistic proxy and tangential studies contribute only to the mechanistic score.
- All linked studies are tangential or mechanistic proxies — no direct test of the claim has been found.
- No clinical evidence is available; the score reflects mechanistic plausibility only.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Systematic Review and Meta-Analysis of Vitamin D Status and Risk of Alzheimer’s and Parkinson’s Disease in Adult Populations
Population: Adults aged 50+ with baseline vitamin D measurements; Intervention: None (observational); Comparator: Serum 25(OH)D levels <20 ng/mL vs. ≥30 ng/mL; Outcome: Incidence of Alzheimer’s or Parkinson’s over 10 years; Duration: Minimum 10 years of follow-up.
Randomized Controlled Trial of Vitamin D Supplementation vs Placebo on Cognitive Decline and Parkinson’s Progression in Older Adults
Population: Adults aged 65+ with baseline vitamin D deficiency (<20 ng/mL); Intervention: Daily oral vitamin D3 (4000 IU); Comparator: Placebo; Outcome: Time to diagnosis of Alzheimer’s or Parkinson’s, cognitive test scores, motor function decline; Duration: 5 years.
Prospective Cohort Study of Serum Vitamin D Levels and Incident Neurodegenerative Disease in a Large Adult Population
Population: 10,000 adults aged 50–75 with baseline serum 25(OH)D measured; Intervention: None; Comparator: Stratified by quintiles of vitamin D levels; Outcome: Incident Alzheimer’s or Parkinson’s diagnosed via clinical criteria; Duration: 15 years.
Case-Control Study Comparing Historical Vitamin D Levels in Patients Diagnosed with Alzheimer’s or Parkinson’s vs Age-Matched Controls
Population: 500 patients with confirmed Alzheimer’s or Parkinson’s diagnosis; Comparator: 500 age-, sex-, and location-matched controls without neurodegenerative disease; Intervention: None; Outcome: Archived serum 25(OH)D levels from prior medical records; Duration: Retrospective analysis of samples collected 1–5 years before diagnosis.
In Vitro Study of Vitamin D Receptor Activation on Microglial Inflammation and Neuronal Survival in Human Neural Cell Lines
Population: Human microglial and cortical neuron cell lines; Intervention: Treatment with 1,25-dihydroxyvitamin D3 at physiological concentrations; Comparator: Untreated or vehicle-treated cells; Outcome: Expression of inflammatory cytokines (IL-6, TNF-α), neuronal apoptosis markers, and neurotrophic factors; Duration: 24–72 hours.